Author:
Sánchez del Valle Francisco José,De Nicolás Luis,Fernández Guillermo,Fernández Pedro,Gómez Esther,Aranaz Corral Inmaculada
Abstract
AbstractThere are many surgical techniques (packing, Pringle maneuver, etc.) and hemostatic agents to manage hepatic bleeding in trauma surgery. This study compares the effectiveness of two different types of hemostatic agents, one is an active flowable hemostat and the other is a passive hemostat made of modified absorbable polymers [MAP]. Both surgical technique and hemostatic agents can be used together as a means of controlling bleeding. We have hypothesized that a single hemostatic agent might be as effective as a unique hemostatic surgical technique. Twenty swine were prospectively randomized to receive either active Flowable (Floseal) or passive MAP powder (PerClot) hemostatic agents. We used a novel severe liver injury model that caused exsanguinating hemorrhage. The main outcome measure was total blood loss volume. The total volume of blood loss, from hepatic injury to minute 120, was significantly lower in the Flowable group (407.5 cm3; IqR: 195.0–805.0 cm3) compared to MAP group (1107.5 cm3; IqR: 822.5 to 1544.5 cm3) (Hodges–Lehmann median difference: − 645.0 cm3; 95% CI: − 1144.0 to − 280.0 cm3; p = 0.0087). The rate of blood loss was significantly lower in the flowable group compared with the MAP group as measured from time of injury to minutes 3, 9, 12, and 120 (except for 6 min). The mean arterial pressure gradually recovered in the flowable group by 24 h, whereas in the MAP group, the mean arterial pressure was consistently stayed below baseline values. Kaplan–Meier survival analysis indicated similar rates of death between study groups (Logrank test p = 0.3395). Both the flowable and the MAP hemostatic agents were able to effectively control surgical bleeding in a novel severe liver injury model, however, the flowable gelatin–thrombin agent provided quicker and better bleed control.
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Corral, M., Ferko, N., Hollmann, S., Broder, M. S. & Chang, E. Health and economic outcomes associated with uncontrolled surgical bleeding: A retrospective analysis of the Premier Perspectives Database. ClinicoEconomics Outcomes Res. CEOR 7, 409–421 (2015).
2. Ghadimi, K., Levy, J. H. & Welsby, I. J. Perioperative management of the bleeding patient. Br. J. Anesth. 117(suppl 3), iii18–iii30 (2016).
3. Stokes, M. E. et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv. Res. 11, 135 (2011).
4. Shander, A. Financial and clinical outcomes associated with surgical bleeding complications. Surgery 142(4 Suppl), S20–S25 (2007).
5. Iannitti, D. A., Kim, C., Ito, D. & Epstein, J. Impact of an active hemostatic product treatment approach on bleeding-related complications and hospital costs among inpatient surgeries in the United States. J. Med. Econ. 24(1), 514–523 (2021).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献